Snowden Healthcare required the contracting of feasibility testing and prototyping to be carried out for two new products, as well as carrying out market evaluation to gain customer feedback.
INSTILS grant funding allowed Snowden to accelerate their projects and get the product to market approximately 18 months earlier than it would’ve been without the funding from Medilink East Midlands.
This project is part-funded by the European Regional Development Fund as part of the European Structural and Investment Funds Growth Programme 2014-2020 in England.
The D2N2 Technical Assistance Team members for European Structural and Investment Funds (ESIF)